
News|Articles|December 10, 2015
How the Type of Antiplatelet Agents Can Impact Patient Outcomes
Christopher Betz, PharmD, BCPS, FKSHP, FASHP, professor in the department of clinical and administrative sciences at Sullivan University College of Pharmacy, discusses how the type of antiplatelet agent chosen can impact patient outcomes.
Advertisement
Christopher Betz, PharmD, BCPS, FKSHP, FASHP, professor in the department of clinical and administrative sciences at Sullivan University College of Pharmacy, discusses how the type of antiplatelet agent chosen can impact patient outcomes.
This video was recorded at the 2015 American Society of Health-System Pharmacists Midyear Meeting.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Current Pneumococcal Vaccination Recommendations: A Clinical Update
2
What Pharmacists Should Know About Most Favored Nation as Drug Prices Continue to Rise
3
A Defining Moment for Health System Pharmacy: Advancing Competency, Policy, and Patient Need in 2026
4
FDA Issues CRL to Anaphylm, Sublingual Film Formulation of Dibutepinephrine
5

























